A retrospective cohort study in Canada found that the relative risk for major cardiovascular events with or without heart failure increased in adults ages 18 to 39 years with an eGFR below 80 mL/min/1.73 m2.
19 Sep 2023
The President-elect of the American Medical Women's Association discusses mentorship, advocacy, and more.
1 Sep 2023
Positive airway pressure-adherent patients with heart failure with preserved ejection fraction and obstructive sleep apnea had fewer health care visits, including ED and hospital visits, than nonadherent patients, according to a new industry-funded study.
18 Jul 2023
A prospective analysis of patients with heart failure and reduced ejection fraction in Japan found that the proportion receiving angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, and mineralocorticoid receptor antagonists decreased as physical frailty increased.
20 Jun 2023
An expert discusses causes and effects of health disparities as well as ways to incorporate health equity into the practice of medicine.
1 Jul 2023
A 35-year-old man is evaluated during a routine visit for β-thalassemia intermedia. One year ago, he began requiring erythrocyte transfusions every 4 to 6 months for symptomatic anemia. He has no other symptoms or medical problems, and his only medication is folic acid. Following a physical exam and lab studies, what is the most appropriate additional management?
12 Sep 2023
This month's expert discusses measuring vital signs, orthostatic hypertension, and the cardiac exam in the context of inpatient care.
1 Jul 2023
Adding a sodium-glucose cotransporter-2 inhibitor to standard care had intermediate cost-effectiveness, but replacing an angiotensin-converting enzyme inhibitor with an angiotensin receptor-neprilysin inhibitor was only borderline cost-effective, a modeling study found.
13 Jun 2023
Comanaging cardiology patients after heart failure requires small adjustments, following recent guidelines, and patient involvement in decisions.
1 Jul 2021
Potentially beneficial complementary and alternative medicine (CAM) therapies included omega-3 polyunsaturated fatty acids, coenzyme Q10, D-ribose, and L-carnitine, the American Heart Association (AHA) said.
13 Dec 2022